Status:

COMPLETED

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

Lead Sponsor:

Azura Ophthalmics

Collaborating Sponsors:

Avania

Conditions:

Meibomian Gland Dysfunction

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

AZ202001 is a multicenter study of AZR-MD-001 ointment and AZR-MD-001 vehicle in patients with Meibomian Gland Dysfunction (MGD)

Detailed Description

AZ202001 is a multicenter, double-masked, vehicle-controlled, randomized, parallel group study evaluating the safety, efficacy and tolerability of AZR-MD-001 ointment and AZR-MD-001 vehicle in patient...

Eligibility Criteria

Inclusion

  • Male or female
  • 18 years of age or older
  • Best-corrected visual acuity (BCVA) of 20/40 or better (Snellen equivalent), using the logarithm of the minimum angle of resolution (LogMAR) in each eye
  • Evidence of meibomian gland obstruction
  • Reported dry eye signs and symptoms within the past 3 months

Exclusion

  • Uncontrolled ocular disease (except for MGD and dry eye disease/keratoconjunctivitis sicca) or uncontrolled systemic disease
  • Glaucoma, ocular hypertension, or intraocular pressure (IOP) in either eye at screening ≥24 mm Hg or has planned insertion/removal of glaucoma filtration shunts/devices during the study
  • Corneal abnormality or disorder that impacts normal spreading of the tear film or corneal integrity
  • BCVA worse than 20/40 in either eye
  • Current use of punctal plugs, anticipated insertion during the study, or a history of punctal cautery in either eye

Key Trial Info

Start Date :

July 17 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 6 2021

Estimated Enrollment :

31 Patients enrolled

Trial Details

Trial ID

NCT04391959

Start Date

July 17 2020

End Date

January 6 2021

Last Update

May 16 2022

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Fiona Stapleton

Sydney, New South Wales, Australia

2

Scott A Read

Brisbane, Queensland, Australia

3

Susan Thackwray

Maroochydore, Queensland, Australia

4

Jagrut Lallu

Auckland, New Zealand